前收市價 | 3.0300 |
開市 | 3.1000 |
買盤 | 3.0900 x 100 |
賣出價 | 3.2400 x 100 |
今日波幅 | 3.0000 - 3.4190 |
52 週波幅 | 1.2800 - 5.5100 |
成交量 | |
平均成交量 | 200,678 |
市值 | 250.238M |
Beta 值 (5 年,每月) | 1.34 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -2.4100 |
業績公佈日 | 無 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 14.83 |
Amneal (AMRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
The average of price targets set by Wall Street analysts indicates a potential upside of 193.4% in Century Therapeutics, Inc. (IPSC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
There are penny stocks and then are penny stock picks that are so outrageously wild that they should never be considered unless one is gambling with pocket change. And by pocket change, I’m talking almost literally. You’ve heard the expression about investing no more than you can afford to lose? Here, you don’t even want to get anywhere near that point. Let’s consider a standard sports car. Generally, the rev limiter will kick in at around 6,800 revolutions per minute (RPM). Basically, the purpo